Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sylics was a Netherlands-based preclinical neuroscience contract research organization focused on efficacy testing in rodent in vivo models of neurological and psychiatric disease. The company provided outsourced preclinical research services, including customized mouse models, behavioral phenotyping, stereotactic surgery, EEG/EMG analysis, specialized histopathology, and bioinformatics support. A notable element of its offering was the proprietary AHCODA behavioral analysis platform and related database infrastructure used for automated high-content mouse phenomics and translational behavioral testing. Sylics also marketed bioinformatics capabilities and tools such as CognitionWall to support standardized cognitive and behavioral studies. In January 2023, Sylics was acquired by InnoSer and integrated into InnoSer's Dutch operations, expanding InnoSer's preclinical neurology platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sylics Contract Research.